PEPTIDE
Verified ComparisonLast updated: 15 April 2026

Best Peptides for Glucose Research

Glucose-control peptides are well-approved and studied; this overview ranks by mechanism breadth and clinical evidence.

Compound A

Semaglutide

Metabolic

Evidence
4.3/ 5
A−

Compound B

Tirzepatide

Metabolic

Evidence
4.6/ 5
A
Editor's note
Both are incretin-based and approved; tirzepatide adds GIP for additional glucose support.
CriterionSemaglutideTirzepatide
MechanismGLP-1 onlyGLP-1 + GIP
Glucose control efficacySubstantialSuperior in trials
Approved in AustraliaYesYes
Long-term safety dataExtensiveAccumulating